A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsored by Eli Lilly and Company
About this study
The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.
Enrolling at this location
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Houston, Texas
I'm interestedThis study also enrolls at 50 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.